GSK's severe asthma therapy Nucala could find a new lease of life as a treatment for chronic obstructive pulmonary disease (COPD) after showing a clear benefit in a phase 3 trial. The headline ...
La farmacéutica GSK tocó su máximo trimestral en marzo tras la publicación de datos clínicos, nuevos acuerdos y el respaldo ...
GSK’s share price has fallen a long way from its one-year high, which has only increased the major undervaluation I'd seen in the stock before that. The post GSK’s share price looks a steal to me ...
GlaxoSmithKline’s Nucala (mepolizumab) has gained a new FDA approval for the rare autoimmune disease eosinophilic granulomatosis with polyangiitis (EGPA). Nucala, an interleukin-5 (IL-5 ...
We recently compiled a list of the 12 Best ADR Stocks to Buy According to Hedge Funds. In this article, we are going to take ...
We recently compiled a list of the 12 Best ADR Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against the other best ADR ...
2025 Healthcare & Pharmaceuticalscategory European regulators to review GSK's asthma drug Nucala to treat COPD March 24, 2025 Healthcare & Pharmaceuticalscategory Brazil's Hypera to launch an ...
La FDA autoriza el antibacteriano gepotidacina, primero de clase y primero frente a ITUs en 30 años, mientras que la EMA acepta revisar el uso de mepolizumab para añadirle la EPOC. Los compuestos ...
During an asthma attack, your airways swell, become inflamed, and produce extra mucus. As the muscles around your airways contract, your bronchial tubes narrow. You may cough or wheeze and find it ...
GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback